Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Neurochem Res
    July 2024
  1. GAYGER-DIAS V, Menezes L, Da Silva VF, Stiborski A, et al
    Changes in Astroglial Water Flow in the Pre-amyloid Phase of the STZ Model of AD Dementia.
    Neurochem Res. 2024;49:1851-1862.
    >> Share

    June 2024
  2. SHENG L, Bhalla R
    Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer's Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy.
    Neurochem Res. 2024 Jun 6. doi: 10.1007/s11064-024-04178.
    >> Share

  3. WANG XF, Xiang XH, Wei J, Zhang PB, et al
    Raddeanin A Protects the BRB Through Inhibiting Inflammation and Apoptosis in the Retina of Alzheimer's Disease.
    Neurochem Res. 2024 Jun 4. doi: 10.1007/s11064-024-04145.
    >> Share

    May 2024
  4. QIU NZ, Hou HM, Guo TY, Lv YL, et al
    Phosphodiesterase 8 (PDE8): Distribution and Cellular Expression and Association with Alzheimer's Disease.
    Neurochem Res. 2024 May 23. doi: 10.1007/s11064-024-04156.
    >> Share

  5. KUEDO Z, Binlateh T, Benjakul S, Hutamekalin P, et al
    Pretreatment with Liposome-Encapsulated Shrimp Shell Extract Attenuated Neuronal Damage and Death in Abeta(1-42)-Induced Memory Deficits in Rats.
    Neurochem Res. 2024;49:1166-1187.
    >> Share

    March 2024
  6. XIAO X, Rui Y, Jin Y, Chen M, et al
    Relationship of Sleep Disorder with Neurodegenerative and Psychiatric Diseases: An Updated Review.
    Neurochem Res. 2024;49:568-582.
    >> Share

    February 2024
  7. ZHANG LJ, Zhang HZ, Liu YW, Tang M, et al
    Sulphated Fucooligosaccharide from Sargassum Horneri: Structural Analysis and Anti-Alzheimer Activity.
    Neurochem Res. 2024 Feb 2. doi: 10.1007/s11064-024-04107.
    >> Share

  8. ALLNUTT MA, Matera KM
    Stabilization and Reduced Cytotoxicity of Amyloid Beta Aggregates in the Presence of Catechol Neurotransmitters.
    Neurochem Res. 2024;49:379-387.
    >> Share

  9. DHALIWAL N, Dhaliwal J, Chopra K
    7, 8-dihydroxyflavone Ameliorates Cholinergic Dysfunction, Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Vascular Dementia.
    Neurochem Res. 2024 Feb 1. doi: 10.1007/s11064-023-04090.
    >> Share

    January 2024
  10. LIU Y, Meng XK, Shao WZ, Liu YQ, et al
    miR-34a/TAN1/CREB Axis Engages in Alleviating Oligodendrocyte Trophic Factor-Induced Myelin Repair Function and Astrocyte-Dependent Neuroinflammation in the Early Stages of Alzheimer's Disease: The Anti-Neurodegenerative Effect of Treadmill Exercise.
    Neurochem Res. 2024 Jan 30. doi: 10.1007/s11064-024-04108.
    >> Share

  11. TAKANO-KAWABE K, Matoba K, Nakamura Y, Moriyama M, et al
    Low Density Lipoprotein Receptor-related Protein 2 Expression and Function in Cultured Astrocytes and Microglia.
    Neurochem Res. 2024;49:199-211.
    >> Share

  12. NADERI S, Motamedi F, Pourbadie HG, Rafiei S, et al
    Neuroprotective Effects of Ferrostatin and Necrostatin Against Entorhinal Amyloidopathy-Induced Electrophysiological Alterations Mediated by voltage-gated Ca(2+) Channels in the Dentate Gyrus Granular Cells.
    Neurochem Res. 2024;49:99-116.
    >> Share

    November 2023
  13. ZHAN Q, Kong F, Shao S, Zhang B, et al
    Pathogenesis of Depression in Alzheimer's Disease.
    Neurochem Res. 2023 Nov 28. doi: 10.1007/s11064-023-04061.
    >> Share

    October 2023
  14. SASIDHARAN R, Mohanan R, Kukreti N, Raj P, et al
    MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer's Disease.
    Neurochem Res. 2023 Oct 9. doi: 10.1007/s11064-023-04031.
    >> Share

    September 2023
  15. WU Z, Tang W, Ibrahim FEEM, Chen X, et al
    Abeta Induces Neuroinflammation and Microglial M1 Polarization via cGAS-STING-IFITM3 Signaling Pathway in BV-2 Cells.
    Neurochem Res. 2023;48:2881-2894.
    >> Share

  16. ASGHAR H, Ahmed T
    Comparative Study of Time-Dependent Aluminum Exposure and Post-Exposure Recovery Shows Better Improvement in Synaptic Changes and Neuronal Pathology in Rat Brain After Short-Term Exposure.
    Neurochem Res. 2023;48:2731-2753.
    >> Share

    August 2023
  17. PANG LW, Hamzah S, Tan SLJ, Mah SH, et al
    The Effects and Mechanisms of Xanthones in Alzheimer's Disease: A Systematic Review.
    Neurochem Res. 2023 Aug 14. doi: 10.1007/s11064-023-04005.
    >> Share

    May 2023
  18. ZHOU Y, Wang Y, Wang Y, Chen L, et al
    LncRNA NKILA Exacerbates Alzheimer's Disease Progression by Regulating the FOXA1-Mediated Transcription of TNFAIP1.
    Neurochem Res. 2023 May 23. doi: 10.1007/s11064-023-03944.
    >> Share

    April 2023
  19. SIDDIQUI N, Ali J, Parvez S, Najmi AK, et al
    Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease.
    Neurochem Res. 2023 Apr 20. doi: 10.1007/s11064-023-03924.
    >> Share

  20. LIM D, Tapella L, Dematteis G, Talmon M, et al
    Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions.
    Neurochem Res. 2023;48:1077-1090.
    >> Share

  21. HUFFELS CFM, Middeldorp J, Hol EM
    Ass Pathology and Neuron-Glia Interactions: A Synaptocentric View.
    Neurochem Res. 2023;48:1026-1046.
    >> Share

    February 2023
  22. ZHANG X, Subbanna S, Williams CRO, Canals-Baker S, et al
    Anti-inflammatory Action of BT75, a Novel RARalpha Agonist, in Cultured Microglia and in an Experimental Mouse Model of Alzheimer's Disease.
    Neurochem Res. 2023 Feb 13. doi: 10.1007/s11064-023-03888.
    >> Share

  23. GUO S, Lei Q, Guo H, Yang Q, et al
    Edaravone Attenuates Abeta 1-42-Induced Inflammatory Damage and Ferroptosis in HT22 Cells.
    Neurochem Res. 2023;48:570-578.
    >> Share

  24. SHARMA V, Singh TG, Kaur A, Mannan A, et al
    Brain-Derived Neurotrophic Factor: A Novel Dynamically Regulated Therapeutic Modulator in Neurological Disorders.
    Neurochem Res. 2023;48:317-339.
    >> Share

    November 2022
  25. AL-KURAISHY HM, Al-Gareeb AI, Alsayegh AA, Hakami ZH, et al
    A Potential Link Between Visceral Obesity and Risk of Alzheimer's Disease.
    Neurochem Res. 2022 Nov 21. doi: 10.1007/s11064-022-03817.
    >> Share

  26. LIU M, Lian B, Lan Z, Sun H, et al
    Transcriptomic Profile Identifies Hippocampal Sgk1 as the Key Mediator of Ovarian Estrogenic Regulation on Spatial Learning and Memory and Abeta Accumulation.
    Neurochem Res. 2022;47:3369-3384.
    >> Share

    October 2022
  27. WU Y, Hang Z, Lei T, Du H, et al
    Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones.
    Neurochem Res. 2022 Oct 30. pii: 10.1007/s11064-022-03784.
    >> Share

  28. KIRSTEIN M, Cambrils A, Segarra A, Melero A, et al
    Cholinergic Senescence in the Ts65Dn Mouse Model for Down Syndrome.
    Neurochem Res. 2022;47:3076-3092.
    >> Share

    September 2022
  29. SEYEDAGHAMIRI F, Rajabi M, Mohaddes G
    Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments.
    Neurochem Res. 2022 Sep 1. pii: 10.1007/s11064-022-03734.
    >> Share

  30. HAMAGUCHI T, Ono K, Yamada M
    Transmission of Cerebral beta-Amyloidosis Among Individuals.
    Neurochem Res. 2022;47:2469-2477.
    >> Share

  31. NOPPARAT C, Chaopae W, Boontem P, Sopha P, et al
    Melatonin Attenuates High Glucose-Induced Changes in Beta Amyloid Precursor Protein Processing in Human Neuroblastoma Cells.
    Neurochem Res. 2022;47:2568-2579.
    >> Share

    August 2022
  32. BHATIA S, Singh M, Singh T, Singh V, et al
    Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer's Disease.
    Neurochem Res. 2022 Aug 20. pii: 10.1007/s11064-022-03722.
    >> Share

  33. DE ALMEIDA EJR, Ibrahim HJ, Chitolina Schetinger MR, de Andrade CM, et al
    Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.
    Neurochem Res. 2022 Aug 13. pii: 10.1007/s11064-022-03713.
    >> Share

  34. LUO JS, Ning JQ, Chen ZY, Li WJ, et al
    The Role of Mitochondrial Quality Control in Cognitive Dysfunction in Diabetes.
    Neurochem Res. 2022;47:2158-2172.
    >> Share

  35. WANG X, Li B, Yu X, Zhou Y, et al
    The Neuroprotective Effect of GM-1 Ganglioside on the Amyloid-Beta-Induced Oxidative Stress in PC-12 Cells Mediated by Nrf-2/ARE Signaling Pathway.
    Neurochem Res. 2022;47:2405-2415.
    >> Share

  36. IBI D, Kondo S, Ohmi A, Kojima Y, et al
    Preventive Effect of Betaine Against Cognitive Impairments in Amyloid beta Peptide-Injected Mice Through Sirtuin1 in Hippocampus.
    Neurochem Res. 2022;47:2333-2344.
    >> Share

    July 2022
  37. KHEZRI MR, Ghasemnejad-Berenji M
    Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Neurochem Res. 2022 Jul 8. pii: 10.1007/s11064-022-03667.
    >> Share

    June 2022
  38. CHINO K, Izuo N, Noike H, Uno K, et al
    Shati/Nat8l Overexpression Improves Cognitive Decline by Upregulating Neuronal Trophic Factor in Alzheimer's Disease Model Mice.
    Neurochem Res. 2022 Jun 27. pii: 10.1007/s11064-022-03649.
    >> Share

    May 2022
  39. EL-GANAINY SO, Soliman OA, Ghazy AA, Allam M, et al
    Intranasal Oxytocin Attenuates Cognitive Impairment, beta-Amyloid Burden and Tau Deposition in Female Rats with Alzheimer's Disease: Interplay of ERK1/2/GSK3beta/Caspase-3.
    Neurochem Res. 2022 May 20. pii: 10.1007/s11064-022-03624.
    >> Share

  40. THENMOZHI AJ, Raja TRW, Janakiraman U, Manivasagam T, et al
    Correction to: Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer's Disease in Wistar Rats.
    Neurochem Res. 2022 May 4. pii: 10.1007/s11064-022-03616.
    >> Share

  41. MANDAL PK, Guha Roy R, Samkaria A, Maroon JC, et al
    In Vivo (13)C Magnetic Resonance Spectroscopy for Assessing Brain Biochemistry in Health and Disease.
    Neurochem Res. 2022;47:1183-1201.
    >> Share

  42. ERDOGAN MA, Kirazlar M, Yigitturk G, Erbas O, et al
    Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia.
    Neurochem Res. 2022;47:1290-1298.
    >> Share

    April 2022
  43. GHOLIPOUR P, Komaki A, Parsa H, Ramezani M, et al
    Therapeutic Effects of High-Intensity Interval Training Exercise Alone and Its Combination with Ecdysterone Against Amyloid Beta-Induced Rat Model of Alzheimer's Disease: A Behavioral, Biochemical, and Histological Study.
    Neurochem Res. 2022 Apr 29. pii: 10.1007/s11064-022-03603.
    >> Share

    March 2022
  44. SUNKARIA A, Bhardwaj S
    Sleep Disturbance and Alzheimer's Disease: The Glial Connection.
    Neurochem Res. 2022 Mar 18. pii: 10.1007/s11064-022-03578.
    >> Share

  45. NGUYEN TT, Hulme J, Vo TK, Van Vo G, et al
    The Potential Crosstalk Between the Brain and Visceral Adipose Tissue in Alzheimer's Development.
    Neurochem Res. 2022 Mar 17. pii: 10.1007/s11064-022-03569.
    >> Share

  46. MENG S, Wang B, Li W
    CircAXL Knockdown Alleviates Abeta1-42-Induced Neurotoxicity in Alzheimer's Disease via Repressing PDE4A by Releasing miR-1306-5p.
    Neurochem Res. 2022 Mar 1. pii: 10.1007/s11064-022-03563.
    >> Share

    February 2022
  47. FRONZA MG, Sacramento M, Alves D, Pratico D, et al
    1-(7-Chloroquinolin-4-yl)-N-(4-Methoxybenzyl)-5-Methyl-1H-1,2, 3-Triazole-4- carboxamide Reduces Abeta Formation and Tau Phosphorylation in Cellular Models of Alzheimer's Disease.
    Neurochem Res. 2022 Feb 15. pii: 10.1007/s11064-021-03514.
    >> Share

  48. SHARMA VK, Singh TG, Prabhakar NK, Mannan A, et al
    Kynurenine Metabolism and Alzheimer's Disease: The Potential Targets and Approaches.
    Neurochem Res. 2022 Feb 8. pii: 10.1007/s11064-022-03546.
    >> Share

  49. SHUKLA M, Wongchitrat P, Govitrapong P
    A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease Pathogenesis.
    Neurochem Res. 2022 Feb 5. pii: 10.1007/s11064-022-03530.
    >> Share

    January 2022
  50. POLIS B, Squillario M, Gurevich V, Srikanth KD, et al
    Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice.
    Neurochem Res. 2022 Jan 31. pii: 10.1007/s11064-021-03519.
    >> Share

  51. YU H, Shi J, Lin Y, Zhang Y, et al
    Icariin Ameliorates Alzheimer's Disease Pathology by Alleviating Myelin Injury in 3 x Tg-AD Mice.
    Neurochem Res. 2022 Jan 17. pii: 10.1007/s11064-021-03507.
    >> Share

    December 2021
  52. LIU M, Zhang X, Wang Y
    Curcumin Alleviates Abeta42-Induced Neuronal Metabolic Dysfunction via the Thrb/SIRT3 Axis and Improves Cognition in APPTG Mice.
    Neurochem Res. 2021;46:3166-3178.
    >> Share

    October 2021
  53. ROE K
    An Alternative Explanation for Alzheimer's Disease and Parkinson's Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins.
    Neurochem Res. 2021 Oct 20. pii: 10.1007/s11064-021-03467.
    >> Share

  54. VERKERKE M, Hol EM, Middeldorp J
    Physiological and Pathological Ageing of Astrocytes in the Human Brain.
    Neurochem Res. 2021;46:2662-2675.
    >> Share

    September 2021
  55. WAN T, Fu M, Jiang Y, Jiang W, et al
    Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease.
    Neurochem Res. 2021 Sep 13. pii: 10.1007/s11064-021-03448.
    >> Share

  56. JIANG P, Chen L, Xu J, Liu W, et al
    Neuroprotective Effects of Rhynchophylline Against Abeta1-42-Induced Oxidative Stress, Neurodegeneration, and Memory Impairment Via Nrf2-ARE Activation.
    Neurochem Res. 2021;46:2439-2450.
    >> Share

    August 2021
  57. SHARMA VK, Singh TG, Singh S, Garg N, et al
    Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential.
    Neurochem Res. 2021 Aug 12. pii: 10.1007/s11064-021-03418.
    >> Share

  58. KAUR D, Behl T, Sehgal A, Singh S, et al
    Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
    Neurochem Res. 2021 Aug 6. pii: 10.1007/s11064-021-03415.
    >> Share

    May 2021
  59. ELFOULY A, Awny M, Ibrahim MK, Aboelsaad M, et al
    Effects of Long-Acting Testosterone Undecanoate on Behavioral Parameters and Na + , K(+)-ATPase mRNA Expression in Mice with Alzheimer`s Disease.
    Neurochem Res. 2021 May 25. pii: 10.1007/s11064-021-03357.
    >> Share

  60. XIAN-HUI D, Dong-Xue M, Tian-Ci Z, Xiao-Ping H, et al
    The Effect of TCM-Induced HAMP on Key Enzymes in the Hydrolysis of AD Model Cells.
    Neurochem Res. 2021;46:1068-1080.
    >> Share

    April 2021
  61. LEHMANN L, Lo A, Knox KM, Barker-Haliski M, et al
    Alzheimer's Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation.
    Neurochem Res. 2021 Apr 30. pii: 10.1007/s11064-021-03332.
    >> Share

  62. NAZIR S, Anwar F, Saleem U, Ahmad B, et al
    Drotaverine Inhibitor of PDE4: Reverses the Streptozotocin Induced Alzheimer's Disease in Mice.
    Neurochem Res. 2021 Apr 20. pii: 10.1007/s11064-021-03327.
    >> Share

  63. UDDIN MS, Sumsuzzman DM, Jeandet P, Behl T, et al
    Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.
    Neurochem Res. 2021 Apr 19. pii: 10.1007/s11064-021-03325.
    >> Share

  64. CAO B, Zeng M, Zhang Q, Zhang B, et al
    Amentoflavone Ameliorates Memory Deficits and Abnormal Autophagy in Abeta25-35-Induced Mice by mTOR Signaling.
    Neurochem Res. 2021;46:921-934.
    >> Share

  65. HACIOGLU C, Kar F, Kanbak G
    Ex Vivo Investigation of Bexarotene and Nicotinamide Function as a Protective Agent on Rat Synaptosomes Treated with Abeta(1-42).
    Neurochem Res. 2021;46:804-818.
    >> Share

    March 2021
  66. SALCEDO C, Wagner A, Andersen JV, Vinten KT, et al
    Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease.
    Neurochem Res. 2021 Mar 12. pii: 10.1007/s11064-021-03276.
    >> Share

  67. BABAEI P, Eyvani K, Kouhestani S
    Sex-Independent Cognition Improvement in Response to Kaempferol in the Model of Sporadic Alzheimer's Disease.
    Neurochem Res. 2021 Mar 12. pii: 10.1007/s11064-021-03289.
    >> Share

    February 2021
  68. LI J, Xu C, Zhang J, Jin C, et al
    Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer's Disease Using Bioinformatic Analyses.
    Neurochem Res. 2021 Feb 13. pii: 10.1007/s11064-020-03215.
    >> Share

  69. XU Y, Cheng L, Sun J, Li F, et al
    Hypermethylation of Mitochondrial Cytochrome b and Cytochrome c Oxidase II Genes with Decreased Mitochondrial DNA Copy Numbers in the APP/PS1 Transgenic Mouse Model of Alzheimer's Disease.
    Neurochem Res. 2021 Feb 12. pii: 10.1007/s11064-020-03192.
    >> Share

  70. LIU X, Wang K, Wei X, Xie T, et al
    Interaction of NF-kappaB and Wnt/beta-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments.
    Neurochem Res. 2021 Feb 1. pii: 10.1007/s11064-021-03227.
    >> Share

  71. GAO Y, Zhang J, Li S, Zhang Y, et al
    Cattle Encephalon Glycoside and Ignotin Protects Neurons Against Microglia-Induced Neuroinflammation via Elevating BDNF Expression and Inhibiting TLR4/NF-kappaB Pathway.
    Neurochem Res. 2021;46:326-336.
    >> Share

  72. CHU F, Li K, Li X, Xu L, et al
    Graphene Oxide Ameliorates the Cognitive Impairment Through Inhibiting PI3K/Akt/mTOR Pathway to Induce Autophagy in AD Mouse Model.
    Neurochem Res. 2021;46:309-325.
    >> Share

    January 2021
  73. ALI M, Saleem U, Anwar F, Imran M, et al
    Screening of Synthetic Isoxazolone Derivative Role in Alzheimer's Disease: Computational and Pharmacological Approach.
    Neurochem Res. 2021 Jan 24. pii: 10.1007/s11064-021-03229.
    >> Share

  74. LARANJINHA J, Nunes C, Ledo A, Lourenco C, et al
    The Peculiar Facets of Nitric Oxide as a Cellular Messenger: From Disease-Associated Signaling to the Regulation of Brain Bioenergetics and Neurovascular Coupling.
    Neurochem Res. 2021;46:64-76.
    >> Share

  75. GONZALEZ A
    Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.
    Neurochem Res. 2021;46:34-50.
    >> Share

    November 2020
  76. BALCAR VJ, Zeman T, Janout V, Janoutova J, et al
    Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer's Disease in a Central European Population.
    Neurochem Res. 2020 Nov 18. pii: 10.1007/s11064-020-03176.
    >> Share

  77. BAGHERI-MOHAMMADI S
    Microglia in Alzheimer's Disease: The Role of Stem Cell-Microglia Interaction in Brain Homeostasis.
    Neurochem Res. 2020 Nov 10. pii: 10.1007/s11064-020-03162.
    >> Share

  78. DING Y, Liu H, Cen M, Tao Y, et al
    Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
    Neurochem Res. 2020 Nov 2. pii: 10.1007/s11064-020-03160.
    >> Share

    October 2020
  79. ORTIZ CJC, Damasio CM, Pruccoli L, Nadur NF, et al
    Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases.
    Neurochem Res. 2020 Oct 20. pii: 10.1007/s11064-020-03148.
    >> Share

    April 2020
  80. GE Y, Song X, Liu J, Liu C, et al
    The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Abeta25-35 Induced Neuronal Injury Through Regulating the Expression of miR-132-3p in Neuronal Cells.
    Neurochem Res. 2020;45:741-751.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016